Huiping Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA modifications and cancer 12
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 7
- Co-authors
- Xiaochun Dong (1 shared paper)Yi Lü (1 shared paper)Wei Wu (1 shared paper)Jianping Qi (1 shared paper)Xiongwei Hu (1 shared paper)Weili Zhao (1 shared paper)Gang Chen (23 shared papers)Xiaoling Gao (4 shared papers)
- Journals
- AIAA Journal (4 papers)Advanced Drug Delivery Reviews (2 papers)PeerJ (2 papers)Oncology Reports (2 papers)ASAIO Journal (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Huiping Lu
62 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 201
- Biomaterials 144
- Pharmaceutical Science 56
- Molecular Biology 455
- Biomedical Engineering 230
Countries citing papers authored by Huiping Lu
This map shows the geographic impact of Huiping Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiping Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiping Lu more than expected).
Fields of papers citing papers by Huiping Lu
This network shows the impact of papers produced by Huiping Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiping Lu. The network helps show where Huiping Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Huiping Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 231 | |
| 2 | 2020 | 86 | |
| 3 | 2015 | 76 | |
| 4 | 2019 | 54 | |
| 5 | 2015 | 53 | |
| 6 | 1983 | 53 | |
| 7 | 2022 | 44 | |
| 8 | 2018 | 34 | |
| 9 | 2018 | 25 | |
| 10 | 2019 | 24 | |
| 11 | 1993 | 22 | |
| 12 | 1977 | 22 | |
| 13 | 2020 | 20 | |
| 14 | 2023 | 19 | |
| 15 | 2023 | 17 | |
| 16 | 2018 | 16 | |
| 17 | 2018 | 16 | |
| 18 | Integrated assessment of CDK1 upregulation in thyroid cancer. | 2019 | 16 |
| 19 | 2020 | 16 | |
| 20 | 2018 | 14 |
About Huiping Lu
Huiping Lu is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Aerospace Engineering, having authored 65 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (12 papers), Aerodynamics and Acoustics in Jet Flows (10 papers), Ferroptosis and cancer prognosis (8 papers), MicroRNA in disease regulation (7 papers), Acoustic Wave Phenomena Research (5 papers), Wind and Air Flow Studies (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). The work is most often cited by research in Cancer Research (201 citations), Biomaterials (144 citations), Pharmaceutical Science (56 citations), Molecular Biology (455 citations) and Biomedical Engineering (230 citations). Huiping Lu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaochun Dong, Yi Lü, Wei Wu, Jianping Qi, Xiongwei Hu, Weili Zhao, Gang Chen, Xiaoling Gao, Qing Lü and Xiaoqi Pan. Their work appears in journals such as AIAA Journal, Advanced Drug Delivery Reviews, PeerJ, Oncology Reports and ASAIO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.